157 related articles for article (PubMed ID: 26397139)
1. Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin.
Lakshmanan A; Scarberry D; Green JA; Zhang X; Selmi-Ruby S; Jhiang SM
Oncotarget; 2015 Oct; 6(31):31792-804. PubMed ID: 26397139
[TBL] [Abstract][Full Text] [Related]
2. Apigenin in combination with Akt inhibition significantly enhances thyrotropin-stimulated radioiodide accumulation in thyroid cells.
Lakshmanan A; Doseff AI; Ringel MD; Saji M; Rousset B; Zhang X; Jhiang SM
Thyroid; 2014 May; 24(5):878-87. PubMed ID: 24400871
[TBL] [Abstract][Full Text] [Related]
3. High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells.
Fiore AP; Fuziwara CS; Kimura ET
Thyroid; 2009 Nov; 19(11):1249-56. PubMed ID: 19725779
[TBL] [Abstract][Full Text] [Related]
4. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.
Vadysirisack DD; Venkateswaran A; Zhang Z; Jhiang SM
Endocr Relat Cancer; 2007 Jun; 14(2):421-32. PubMed ID: 17639055
[TBL] [Abstract][Full Text] [Related]
5. Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.
Liu YY; Zhang X; Ringel MD; Jhiang SM
Endocr Relat Cancer; 2012 Jun; 19(3):291-304. PubMed ID: 22355179
[TBL] [Abstract][Full Text] [Related]
6. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
[TBL] [Abstract][Full Text] [Related]
7. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of heat shock protein 90, a novel RET/PTC1-associated protein, increases radioiodide accumulation in thyroid cells.
Marsee DK; Venkateswaran A; Tao H; Vadysirisack D; Zhang Z; Vandre DD; Jhiang SM
J Biol Chem; 2004 Oct; 279(42):43990-7. PubMed ID: 15302866
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
12. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
13. Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands.
Cho JY; Léveillé R; Kao R; Rousset B; Parlow AF; Burak WE; Mazzaferri EL; Jhiang SM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2936-43. PubMed ID: 10946907
[TBL] [Abstract][Full Text] [Related]
14. Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.
Hou P; Bojdani E; Xing M
J Clin Endocrinol Metab; 2010 Feb; 95(2):820-8. PubMed ID: 20008023
[TBL] [Abstract][Full Text] [Related]
15. Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).
Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Stoker TE; Laws SC
Toxicol In Vitro; 2017 Apr; 40():66-78. PubMed ID: 27979590
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 suppresses thyrotropin-induced Na+/I- symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells.
Kawaguchi A; Ikeda M; Endo T; Kogai T; Miyazaki A; Onaya T
Thyroid; 1997 Oct; 7(5):789-94. PubMed ID: 9349586
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the sodium/iodide symporter explains 131I-induced thyroid stunning.
Nordén MM; Larsson F; Tedelind S; Carlsson T; Lundh C; Forssell-Aronsson E; Nilsson M
Cancer Res; 2007 Aug; 67(15):7512-7. PubMed ID: 17671222
[TBL] [Abstract][Full Text] [Related]
19. Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma.
Gaertner FC; Rohde F; Mueller J; Blechert B; Janssen KP; Essler M
Int J Cancer; 2009 Dec; 125(12):2783-91. PubMed ID: 19569179
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I- symporter messenger ribonucleic acid levels in FRTL-5 cells.
Pekary AE; Hershman JM
Endocrinology; 1998 Feb; 139(2):703-12. PubMed ID: 9449644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
